To investigate the therapeutic effects of anti-inflammatory drug on AD animal models of different ages, we employed MON, a highly selective antagonist of CysLT1R, which primarily exerts its pharmacological effects on pro-inflammatory cytokines. Here, CYSLTR1 is linked to Alzheimer disease.